Ticker

6/recent/ticker-posts

Infosys Announces Kiran Mazumdar-Shaw's Retirement From Board

Infosys nowadays introduced the retirement of Kiran Mazumdar-Shaw as Independent Director from its Board, powerful March 22, 2023, upon of of entirety of her tenure.

Accordingly, the Board has appointed D Sundaram because the Lead Independent Director of the Company, powerful Thursday primarily based totally on the advice of the `Nomination and Remuneration Committee'.

D Sundaram has been at the Board of Infosys in view that 2017. D Sundaram serves at the Audit Committee, Risk Management Committee, Stakeholders Relationship Committee, Nomination and Remuneration Committee, and Cybersecurity Risk Sub-Committee.

"We profusely thank Kiran Mazumdar-Shaw for having been such an quintessential member of the Infosys family, offering precious steerage and management to the Board over the years. I am individually very thankful to her as she has been a extraordinary best friend and wonderful colleague at the Board, ever in view that I re-joined Infosys in August 2017," Infosys Chairman, Nandan Nilekani, stated.

"We additionally congratulate D Sundaram on being appointed as Lead Independent Director and stay up for his endured perception and steadfast guide as Infosys keeps its boom and transformation journey," Nilekani added.

Kiran Mazumdar-Shaw turned into appointed to the Infosys' Board as an Independent Director in 2014, and as Lead Independent Director in 2018.

She additionally served because the Chairperson of the 'Nomination & Remuneration Committee' and 'CSR Committee', and as a member of the 'Risk Management and ESG Committees' of the Board.

"The Board locations on file its appreciation for Ms Shaw's helpful contribution, steerage, and strategic vision, that has helped the Company construct and execute a resilient boom strategy," Infosys stated in a release.

Kiran Mazumdar-Shaw is the Chairperson and Managing Director of Biocon Limited, a biotechnology business enterprise primarily based totally in Bangalore, India.

Post a Comment

0 Comments